Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review

Document Sample
Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					             Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDRT28135FSA                                                                                          Publication Date: AUG 2012

          Neckartalstrasse 155                               Phone               +49 711 500100                 Revenue          23,283.90 (million EUR)
          Stuttgart, Baden-Wurttemberg                       Fax                 +49 711 50011260               Net Profit       2.20 (million EUR)
          70376                                              Website             www.celesio.com                Employees        29,263
          Germany                                            Exchange            CLS1 [XETRA]                   Industry         Retailing

       Company Overview
       Celesio AG (Celesio) is an international trade, logistics and service company. It provides various services for pharmaceutical and
       healthcare markets in Europe. The company operates its business through three divisions, namely, Patient and Consumer
       Solutions, Pharmacy Solutions, and Manufacturer Solutions. Celesio operates more than 2,200 pharmacies, which provides
       drugs and innovative health related services to patients. The company operates approximately 140 wholesale branches to deliver
       medicines to reach out nearly 65,000 pharmacies. Celesio also provides pharmaceutical manufacturers with logistics and
       distribution services. The company has operations in 27 countries.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Celesio AG, SWOT Analysis
         Dr. Marion Helmes                   Chief Financial Officer                  Strengths                              Weaknesses
         Markus Pinger                       Chairman
                                                                                      Pharmacies Chain                       Weak Profitability Indicators
         Stephan Borchert                    Member      of                the
                                             Management Board                         Strategic Business Units               Increasing Debt Burden
         Wolfgang Mahr                       Member      of                the
                                             Management Board                         Opportunities                          Threats
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Growing Opportunities in E-            Competitive Landscape
       Share Data                                                                     Retailing
                                                                                                                             Global Economic Scenario
         Celesio AG                                                                   Market Potential: Healthcare
                                                                                      and Pharmaceutical
        Share Price (EUR) as on 03-Aug-                                14.78
        2012
        EPS (EUR)                                                        0.01        Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Market Cap (million EUR)                                       2,115
        Enterprise Value (million EUR)                                 3,784
        Shares Outstanding (million)                                     170
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 14, 2012         Celesio Reports Revenue Of €5.6 Billion In Q1
                                                                                                           2012
                                                                                      Jan 31, 2012         Celesio Reports Revenue Of €23 Billion In
                                                                                                           2011
                                                                                      Dec 20, 2011         Celesio Appoints Marion Helmes As CFO
                                                                                      Nov 07, 2011         Celesio Reports Revenue Of €17.2 Billion In
                                                                                                           Q3 2011
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData

       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Celesio AG (CLS1) - Financial and Strategic SWOT Analysis                                                                      Reference Code: GDRT28135FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Celesio AG - Key Facts ...................................................................................................................................................................... 4
       Celesio AG - Key Employees ............................................................................................................................................................. 5
       Celesio AG - Key Employee Biographies ........................................................................................................................................... 6
       Celesio AG - Major Products and Services ........................................................................................................................................ 7
       Celesio AG - History ........................................................................................................................................................................... 8
       Celesio AG - Company Statement ................................................................................................................................................... 10
       Celesio AG - Locations And Subsidiaries ......................................................................................................................................... 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Section 2 – Company Analysis ......................................................................................................................................................... 15
       Celesio AG - Business Description................................................................................................................................................... 15
       Celesio AG - SWOT Analysis ........................................................................................................................................................... 16
          SWOT Analysis - Overview........................................................................................................................................................... 16
          Celesio AG - Strengths ................................................................................................................................................................. 16
             Strength - Pharmacies Chain .................................................................................................................................................... 16
             Strength - Strategic Business Units ........................................................................................................................................... 16
             Strength - Awards and Recognitions ......................................................................................................................................... 16
          Celesio AG - Weaknesses ............................................................................................................................................................ 16
             Weakness - Weak Profitability Indicators .................................................................................................................................. 16
             Weakness - Increasing Debt Burden ......................................................................................................................................... 17
          Celesio AG - Opportunities ........................................................................................................................................................... 17
             Opportunity - Growing Opportunities in E-Retailing ................................................................................................................... 17
             Opportunity - Market Potential: Healthcare and Pharmaceutical ............................................................................................... 17
             Opportunity - Business Expansion: Brazil ................................................................................................................................. 17
          Celesio AG - Threats .................................................................................................................................................................... 18
             Threat - Competitive Landscape ............................................................................................................................................... 18
             Threat - Global Economic Scenario........................................................................................................................................... 18
             Threat - Regulated Industry....................................................................................................................................................... 18
       Celesio AG - Key Competitors.......................................................................................................................................................... 19
       Section 3 – Company Financial Ratios ........................................................................................................
				
DOCUMENT INFO
Description: Celesio AG (Celesio) is an international trade, logistics and service company. It provides various services for pharmaceutical and healthcare markets in Europe. The company operates its business through three divisions, namely, Patient and Consumer Solutions, Pharmacy Solutions, and Manufacturer Solutions. Celesio operates more than 2,200 pharmacies, which provides drugs and innovative health related services to patients. The company operates approximately 140 wholesale branches to deliver medicines to reach out nearly 65,000 pharmacies. Celesio also provides pharmaceutical manufacturers with logistics and distribution services. The company has operations in 27 countries. The company is headquartered in Stuttgart, Germany. The company intends to focus on its core business. As recently, the company sold its subsidiary Pharmexx to United Drug, which is an international provider of services to healthcare manufacturers and pharmaceutical retailers. Pharmexx is an international outsourcing solutions provider for sales & marketing to the Pharma and Medtech Industry.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.